Pear Therapeutics’ $20M Series D Extension

Foley Hoag LLP advised Pear Therapeutics, Inc. on the deal.Pear Therapeutics, Inc., a pioneer of prescription digital therapeutics (PDTs), announced the extension of its Series D financing,…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now